Company page

Brightgene Bio-medical Technology Co. Ltd. Class A

Brightgene Bio-medical Technology Co. Ltd. Class A, traded under the ticker 688166, operates in the Chinese market. The company has a market capitalization of approximately 3.4 billion USD. Brightgene focuses on the development and production of innovative biopharmaceuticals and related technologies.

profile688166AI content: aiUpdated May 29, 2026/company/brightgene-bio-medical-technology-c
Brightgene Bio-medical Technology Co. Ltd. Class A logo
Ticker
688166
Market cap
$3.40B
Sector
Health Technology
Industry
Pharmaceuticals: Major